David Roy Repaske, PhD, MD
Title
Medical Director, Diabetes Center.Biochemistry Core Scientific Director
Appointment
Associate Professor of Pediatrics
Email
david.repaske@cchmc.org
Phone
513-636-7356
Fax
513-636-7486
Credentials
AB: Biochemistry, Cornell University, Ithaca, N.Y., 1973.
PhD: University of Wisconsin, Department of Biochemistry, Madison, Wisc., 1980.
MD: Vanderbilt University School of Medicine, Nashville, Tenn., 1985.
Residency:Internal Medicine and Pediatrics, North Carolina Memorial Hospital, University of North Carolina, Chapel Hill, N.C., 1988. Pediatrics, North Carolina Memorial Hospital, University of North Carolina, Chapel Hill, N.C., 1988.
Fellowship: Pediatric Endocrinology, University of North Carolina, Chapel Hill, N.C., 1991, Human Genetics, Vanderbilt University, Division of Genetics, Department of Pediatrics, Nashville, Tenn., 1985-1986.
Certification: Pediatrics, 1992; Pediatric Endocrinology, 1995.
Awards and Honors
Phi Beta Kappa, Cornell University, May 1972
A.B. Degree with honors in biochemistry and distinction in all subjects, May 1973
Invited speaker, 17th International Summer School of Brain Research, Netherlands Institute for Brain Research, Amsterdam, The Netherlands, August 1991
Invited speaker, Division of Reproductive Endocrinology, Stanford University, Stanford, CA, August 1993
Invited speaker, Endocrinology Grand Rounds, "Inherited Diabetes Insipidus", University of New South Wales, Sydney, Australia, March, 1995
Invited speaker, Midwest Teratology Association, "Embryology and Anatomy of Human Genital Development", May 1997
Invited speaker, Gordon Research Conference on Second Messengers and Protein Phosphorylation, "PDE1B Knockout Mouse", Meriden, NH, June 7-11, 1998
Invited speaker, Pediatric Endocrine Tri-State Nurses Association Meeting, "Congenital Adrenal Hyperplasia", September 1998
Invited speaker, Lilly Pediatric Endocrinology Symposium, "Diabetes Insipidus", Nov. 15, 1999
Invited speaker, Pfizer Pharmaceuticals, "PDE1B, from Cloning to Knockout Mouse", Nov. 18, 1999
Invited speaker, Gordon Research Conference on Cyclic Nucleotide Phosphodiesterases, "PDE1B Knockout Mouse", Sept. 10-15, 2000
Research Grants and Contracts
Children's Hospital Medical Center of Cincinnati Trustee Award, "Autosomal Dominant Neurohypophyseal Diabetes Insipidus", Jan. 1, 1997 to Dec. 31, 1997 and Jan. 1, 1998 to Dec. 31, 19998.
National Institutes of Health R01DK52445 "Inherited Hypothalamic Neurodegeneration", July 1, 1997 to June 30, 1998; July 1, 1998 to June 30, 1999; July 1, 1999 to June 30, 2000; July 1, 2000 to June 30, 2001; July 1, 2001 to June 30, 2002.
Pharmacia and Upjohn Contract, "Kabi International Growth Study", July 1, 1997 to June 31, 2002.
Genentech Foundation, "Fingerstick 17-OH-Progesterone Monitoring of CAH Therapy,", March 1, 1998 to Feb. 28, 1999; and March 1, 1999 to Feb. 28, 2000.
Eli Lilly GDDE Contract, Protocol B9R-EW-GDDY, April 1, 1998 to March 31, 1999.
Eli Lilly Fellowship Research Grant, "Molecular and Cellular Pathophysiology of an Inherited Pituitary Hormone Deficiency", June 1, 1998 to May 31, 2000.
March of Dimes #6-FY99-224, "Inherited Hypothalamic Neurodegeneration,", June 1, 1999 to May 31, 2000; June 1, 2000 to May 31, 2001; and June 1, 2001 to May 31, 2002.
Publications, Most Recent
View David Repaske's publications at Cincinnati Children's as listed by PubMed.
Professional Organization Memberships
The Endocrine Society, January 1993
The American Association for the Advancement of Science, March 1993
The Lawson Wilkins Pediatric Endocrine Society, May 1994
American Diabetes Association, May 1997
Society for Pediatric Research, November 1997
Society for Neuroscience, January 1998
Special Interests
Molecular basis of human neuroendocrine disease; neurodegeneration in autosomal dominant diabetes insipidus; regulation of neural signal transduction pathways by cyclic nucleotide phosphodiesterases
Related Areas
This person works in these other areas at Cincinnati Children's Hospital Medical Center:
